Efficacy and Safety of Brolucizumab for Diabetic Macular Edema: The KINGFISHER Randomized Clinical Trial.

Efficacy and Safety of Brolucizumab for Diabetic Macular Edema: The KINGFISHER Randomized Clinical Trial. JAMA Ophthalmol. 2023 Dec 01; 141(12):1152-1160.

View in: PubMed

subject areas

Angiogenesis Inhibitors
Diabetes Mellitus
Diabetic Retinopathy
Female
Humans
Intravitreal Injections
Macular Edema
Male
Middle Aged
Receptors, Vascular Endothelial Growth Factor
Recombinant Fusion Proteins
Treatment Outcome
Vascular Endothelial Growth Factor A

authors with profiles

Veeral Sheth